| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2007518 | Peptides | 2007 | 6 Pages |
Abstract
In conclusion, CNP is activated in patients with LV dysfunction but without coronary artery disease, independently of the presence of overt heart failure and in tune with the extent of myocardial functional involvement. In these patients CNP is also related with both systemic and coronary indicators of endothelial/microvascular damage.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Silvia Del Ry, Daniela Giannessi, Maristella Maltinti, Concetta Prontera, Annalisa Iervasi, Chiara Colotti, Michele Emdin, Antonio L'Abbate, Danilo Neglia,